Exact Mass: 616.4788

Exact Mass Matches: 616.4788

Found 174 metabolites which its exact mass value is equals to given mass value 616.4788, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-15:0)

(2S)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(a-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C38H64O6 (616.4703)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0)

(2S)-3-hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0)

(2S)-3-hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-15:0)

(2S)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C38H64O6 (616.4703)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(i-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C38H64O6 (616.4703)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Bacchalatiofolin

Bacchalatiofolin

C38H64O6 (616.4703)


   

C(19)-Obtusilacton dimer

C(19)-Obtusilacton dimer

C38H64O6 (616.4703)


   

hexyl p-stigmasteryloxy-benzoate|neristigmol

hexyl p-stigmasteryloxy-benzoate|neristigmol

C42H64O3 (616.4855)


   

2-Methoxy-6-all-trans-heptaprenylhydroquinonel

2-Methoxy-6-all-trans-heptaprenylhydroquinonel

C42H64O3 (616.4855)


   

DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(a-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(a-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(i-15:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(i-15:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H64O6 (616.4703)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/15:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/15:0/0:0)

C38H64O6 (616.4703)


   

DG(15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/15:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(a-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(a-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-15:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(a-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(a-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(a-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(a-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-15:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(a-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-15:0/0:0)

C38H64O6 (616.4703)


   

DG(a-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(a-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-15:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(i-15:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H64O6 (616.4703)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-15:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(i-15:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(i-15:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-15:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(i-15:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(i-15:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C38H64O6 (616.4703)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-15:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-15:0)

C38H64O6 (616.4703)


   

DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(i-15:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-15:0/0:0)

C38H64O6 (616.4703)


   

DG(i-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(i-15:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C38H64O6 (616.4703)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-15:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-15:0)

C38H64O6 (616.4703)


   

NAOrn 20:4/12:0

NAOrn 20:4/12:0

C37H64N2O5 (616.4815)


   

NAOrn 18:3/14:1

NAOrn 18:3/14:1

C37H64N2O5 (616.4815)


   

NAOrn 12:0/20:4

NAOrn 12:0/20:4

C37H64N2O5 (616.4815)


   

NAOrn 10:0/22:4

NAOrn 10:0/22:4

C37H64N2O5 (616.4815)


   

NAOrn 14:1/18:3

NAOrn 14:1/18:3

C37H64N2O5 (616.4815)


   

NAOrn 16:3/16:1

NAOrn 16:3/16:1

C37H64N2O5 (616.4815)


   

NAOrn 16:2/16:2

NAOrn 16:2/16:2

C37H64N2O5 (616.4815)


   

NAOrn 22:4/10:0

NAOrn 22:4/10:0

C37H64N2O5 (616.4815)


   

NAOrn 18:4/14:0

NAOrn 18:4/14:0

C37H64N2O5 (616.4815)


   

NAOrn 16:4/16:0

NAOrn 16:4/16:0

C37H64N2O5 (616.4815)


   

NAOrn 16:1/16:3

NAOrn 16:1/16:3

C37H64N2O5 (616.4815)


   

(2-nonanoyloxy-3-octanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

(2-nonanoyloxy-3-octanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C38H64O6 (616.4703)


   

(2-decanoyloxy-3-nonanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(2-decanoyloxy-3-nonanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C38H64O6 (616.4703)


   

(3-octanoyloxy-2-undecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(3-octanoyloxy-2-undecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C38H64O6 (616.4703)


   

2-[Carboxy-[2,3-di(dodecanoyloxy)propoxy]methoxy]ethyl-trimethylazanium

2-[Carboxy-[2,3-di(dodecanoyloxy)propoxy]methoxy]ethyl-trimethylazanium

C34H66NO8+ (616.4788)


   

2-[Carboxy-(2-tridecanoyloxy-3-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(2-tridecanoyloxy-3-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C34H66NO8+ (616.4788)


   

2-[Carboxy-(2-hexadecanoyloxy-3-octanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(2-hexadecanoyloxy-3-octanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C34H66NO8+ (616.4788)


   

2-[Carboxy-(3-decanoyloxy-2-tetradecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(3-decanoyloxy-2-tetradecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C34H66NO8+ (616.4788)


   

2-[Carboxy-(3-nonanoyloxy-2-pentadecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(3-nonanoyloxy-2-pentadecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C34H66NO8+ (616.4788)


   

TG(35:4)

TG(6:0_11:3_18:1)

C38H64O6 (616.4703)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   

(2r,4ar,8r,8as)-8-[(3s)-5-hydroxy-3-methylpentyl]-4,4,7,8a-tetramethyl-1,2,3,4a,5,8-hexahydronaphthalen-2-yl 1-[(1s,4r)-4-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]cyclohexyl]methyl propanedioate

(2r,4ar,8r,8as)-8-[(3s)-5-hydroxy-3-methylpentyl]-4,4,7,8a-tetramethyl-1,2,3,4a,5,8-hexahydronaphthalen-2-yl 1-[(1s,4r)-4-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]cyclohexyl]methyl propanedioate

C38H64O6 (616.4703)


   

hexyl 4-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}benzoate

hexyl 4-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}benzoate

C42H64O3 (616.4855)


   

hexyl 4-{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}benzoate

hexyl 4-{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}benzoate

C42H64O3 (616.4855)